Comparative Analysis of the Safety and Functional Outcomes of Anterior versus Retropupillary Iris-Claw IOL Fixation
Table 3
Outcomes variables at different time points in the two groups.
Group A ()
Group B ()
value
Preop. BCDVA (logMAR)
0.66 ± 0.60
0.80 ± 0.66
N.S.
1-month postop. BCDVA (logMAR)
0.35 ± 0.30
0.50 ± 0.50
1-year postop. BCDVA (logMAR)
0.34 ± 0.45
0.37 ± 0.50
value (preop. to 1 month, preop. to 1 year, 1 month to 1 year)
0.019, <0.001, N.S.
Refractive components
1-year postop. Sphere, D
−0.46 ± 0.65
−1.02 ± 1.51
N.S.
1-year postop. Cylinder, D
1.02 ± 1.51
1.08 ± 0.43
N.S.
CMT
N.S.
Preop. CMT (µm)
227 ± 64
214 ± 54
1-month postop. CMT (µm)
229 ± 61
233 ± 99
1-year postop. CMT (µm)
273 ± 158
229 ± 79
value (any time interval)
N.S.
ECD
N.S.
Preop. ECD, number of cells (mm2)
2043 ± 647
2047 ± 489
1-month postop. ECD, number of cells (mm2)
1721 ± 566
1605 ± 521
1-year postop. ECD, number of cells (mm2)
1512 ± 588
1395 ± 380
value (preop. to 1-month, preop. to 1-year, 1-month to 1-year)
<0.01, <0.01, N.S.
Continuous variables are presented as means ± standard deviation. : number; BCDVA: best-corrected distance visual acuity; D: diopter; CMT: central macular thickness; ECD: endothelial cell density; N.S.: not significant, .
